Table 2. Medication regimens of diabetes patients stratified by BMI and WC.
| BMI (kg/m2) | BMI ≥24kg/m2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Total(n = 24,512) | <24(n = 9866) | 24–27.9(n = 10,548) | ≥28(n = 4098) | P | Normal WC(n = 2904) | Central obesity(n = 6642) | P | |
| Antihypertensive agents | 10577 (43.2) | 3711 (37.6) | 4722 (44.8) | 2144 (52.3) | <0.001 | 1244 (42.8) | 2965 (44.6) | <0.001 |
| Lipid lowering agents | 5776 (23.6) | 1954 (19.8) | 2679 (25.4) | 1143 (27.9) | <0.001 | 715 (24.6) | 1727 (26.0) | 0.473 |
| Oral anti-diabetic agents | 17992 (73.4) | 7140 (72.4) | 7753 (73.5) | 3099 (75.6) | <0.001 | 2019 (69.5) | 4919 (74.1) | <0.001 |
| Metformin | 9460 (38.6) | 3314 (33.6) | 4216 (40.0) | 1930 (47.1) | <0.001 | 1064 (36.6) | 2774 (41.8) | 0.131 |
| α-glucosidase inhibitors | 6527 (26.6) | 2664 (27.0) | 2774 (26.3) | 1089 (26.6) | 0.031 | 696 (24.0) | 1735 (261.) | 0.424 |
| Sulfonylureas | 7075 (28.9) | 3038 (30.8) | 3016 (28.6) | 1021 (24.9) | <0.001 | 752 (25.9) | 1816 (27.3) | 0.664 |
| Thiazolidinediones | 1820 (7.4) | 677 (6.9) | 782 (7.4) | 361 (8.8) | 0.289 | 159 (5.5) | 530 (8.0) | 0.098 |
| Insulin | 8688 (35.4) | 3414 (34.6) | 3788 (35.9) | 1486 (36.3) | 0.072 | 1077 (37.1) | 2334 (35.1) | 0.068 |
Data are expressed as n (%)